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Abstract
Background: HIV counseling and testing may serve as an entry point for non-communicable disease screening.
Objectives: To determine the yield of newly-diagnosed HIV, tuberculosis (TB) symptoms, diabetes and
hypertension, and to assess CD4 count testing, linkage to care as well as correlates of linkage and barriers to care
from a mobile testing unit.
Methods: A mobile unit provided screening for HIV, TB symptoms, diabetes and hypertension in Cape Town, South
Africa between March 2010 and September 2011. The yield of newly-diagnosed cases of these conditions was
measured and clients were followed-up between January and November 2011 to assess linkage. Linkage to care
was defined as accessing care within one, three or six months post-HIV diagnosis (dependent on CD4 count) and
one month post-diagnosis for other conditions. Clinical and socio-demographic correlates of linkage to care were
evaluated using Poisson regression and barriers to care were determined.
Results: Of 9,806 clients screened, the yield of new diagnoses was: HIV (5.5%), TB suspects (10.1%), diabetes
(0.8%) and hypertension (58.1%). Linkage to care for HIV-infected clients, TB suspects, diabetics and hypertensives
was: 51.3%, 56.7%, 74.1% and 50.0%. Only disclosure of HIV-positive status to family members or partners
(RR=2.6, 95% CI: 1.04-6.3, p=0.04) was independently associated with linkage to HIV care. The main barrier to care
reported by all groups was lack of time to access a clinic.
Conclusion: Screening for HIV, TB symptoms and hypertension at mobile units in South Africa has a high yield but
inadequate linkage. After-hours and weekend clinics may overcome a major barrier to accessing care.
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Introduction
Sub-Saharan Africa (SSA) continues to have the highest
prevalence of HIV1 and tuberculosis (TB) [2] worldwide and is
also experiencing substantial non-communicable disease
(NCD) epidemics of hypertension and diabetes, with the
prevalence ranging from 29.2% to 48% and 1-16%,
respectively [3,4,5] Given the successful roll-out of antiretroviral
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therapy (ART) programmes, there is now recognition that HIV
services may be leveraged to provide NCD services [6-8].
Initially, HIV services were provided through vertical
programmes, but due to the overlap in co-morbidities between
HIV and other infectious and non-infectious diseases,
integration of these services is now recommended [8].
Since the launch of South Africa’s HIV counselling and
testing (HCT) campaign in April 2010, approximately 20 million
individuals have been tested for HIV [9]. Given the rapid scale-
up of HCT sites throughout the country and the ability of HCT
programmes to reach large numbers of individuals [1], HCT
may be an effective entry point for NCD screening, as
screening for multiple diseases may allow a more efficient use
of scarce resources [10] and increased opportunities for case-
finding [8]. Furthermore, improved survival of HIV-infected
patients, due to roll-out of ART combined with the increased
risk in these patients for NCDs, will result in a growing burden
of NCDs in this group [11]. Thus, early diagnosis of both
communicable and non-communicable diseases and prompt
linkage to care is critical for an effective public health response.
Studies from developing countries that integrate NCD
screening programmes with HCT are scarce and were all
conducted at healthcare facilities [10,12,13]. One recent study
conducted in Uganda demonstrated the feasibility of integrating
communicable and non-communicable disease screening in a
community HIV testing campaign[14]. Mobile testing units have
proven successful for the delivery of HCT [15-27] and TB
screening [28] at non-healthcare facilities. Combined HIV and
active TB case-finding in a mobile unit was found to be feasible
[29,30] and had a high uptake and yield[30]. A recent
workplace mobile screening program also showed a high yield
of HIV, diabetes and hypertension diagnoses[31]. However, the
success of mobile screening units depends on successful
linkage to clinical care, which may be challenging.
To date, no study has evaluated a mobile unit that combines
infectious and non-infectious disease screening in a resource-
limited setting. The aim of this study was to assess the yield of
clients newly-diagnosed with HIV, TB symptoms, diabetes
and/or hypertension and linkage to HIV and other chronic
disease care from a mobile testing unit.
Methods
Study setting
Mobile testing unit.  A nurse-run and counsellor-supported
mobile unit provided free HCT and additional screening for TB
symptoms, diabetes and hypertension to underserved urban
and peri-urban townships within the Cape Metropolitan region,
Western Cape, South Africa as described elsewhere
[19,22,25,26,29,30]. The daily staff component comprised of
one or two nurses, two or three counsellors, an educator and a
driver. The unit operated five days per week at work sites (i.e.
farms), outside community venues (i.e. churches, schools,
halls, and sports fields), taxi-ranks and shopping centres. Sites
were visited at least once every three months. Posters were
placed at testing sites a day or two before the mobile unit
arrival. On the day of screening staff attracted clients using
flyers and a loudspeaker, furthermore brightly coloured
signboards describing all the free services offered on the
mobile unit were placed in and around the unit. Depending on
the venue, particular groups were targeted (i.e. shopping
centre and roadside: passers-by; schools: pupils and teachers).
Clinical procedures.  Clients were first registered by the
driver using an electronic biometric fingerprint reader [26].
While clients waited to be screened, the educator conducted
health talks (i.e. on sexually transmitted infections (STI),
prevention of mother to child transmission, TB, diabetes,
hypertension). All clients then underwent client-initiated HIV
testing, according to the guidelines of the Provincial Health
Government [32], followed by TB symptom and chronic disease
screening. Screening was performed by a nurse and
counsellor. HIV testing was conducted using the approved
rapid screening test (i.e. Bioline HIV-1/2 3.0, Standard
Diagnostics, Korea) which was followed by the approved rapid
confirmatory test (i.e. Determine HIV-1/2, Abbott Laboratories)
if the first test produced a positive result [32], according to the
South African testing algorithm [33]. Newly-diagnosed HIV-
infected individuals were then clinically staged, according to
WHO guidelines, and had a CD4 count measured using a
point-of-care (POC) machine (Alere PIMA™ Analyzer). A TB
suspect was defined as a client who self-reported one or more
symptoms suggestive of TB (i.e. cough or fever for >2 weeks,
weight loss of >1.5 kgs in the last month, drenching night
sweats, loss of appetite, hemoptysis), according to South
African TB guidelines [34]. Screening for diabetes and
hypertension was performed using hand-held glucometers (SD
Check, Gold, Standard Diagnostics INC, South Korea) and
electronic sphygmomanometers (RossMax, AW150f, Taiwan).
For the purpose of this study, diabetes was defined as a
random blood glucose ≥11.1 mmol/l, and hypertension was
defined as a systolic blood pressure ≥160 mmHg and/or
diastolic blood pressure ≥100 mmHg (“moderate hypertension”)
[35]. Blood pressure was measured following questions
regarding the individuals’ medical history and was taken
without any prior prolonged rest in a seated position as the
design of the mobile did not allow for examination couches in
all rooms. If the blood pressure reading was normal (
< 140/90 mmHg), only one reading was done. If the blood
pressure was ≥ 140/90mmHg, the individual was retested after
several minutes of rest, on the opposite arm. Up to four blood
pressure measurements were performed. The lowest blood
pressure was recorded as the final result.
Individuals diagnosed with HIV, TB symptoms, diabetes and
or hypertension received a referral letter written by the nurse to
facilitate linkage to a healthcare facility. Referrals for other
health services not offered on the mobile unit (i.e. Pap smear,
STI treatment, isoniazid preventive therapy (IPT) if HIV-infected
without TB symptoms, antenatal care, family planning, obesity
counseling, anaemia screening or treatment, nutrition support)
were also documented on this referral letter to enable clients to
access care for these additional conditions. Primary healthcare
clinics in this setting provide a package of care which includes
both HIV, TB and other chronic disease care (i.e. diabetes and
hypertension) as well as antenatal and reproductive health
services [36]. For the purposes of this study, “diagnosis” of
other chronic condition relates to a positive screening test (i.e.
Linkage to Care from a Mobile Testing Unit
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for TB symptoms, diabetes, hypertension) as a confirmed
diagnosis of any one of these conditions required follow-up
testing at a healthcare facility.
Following testing, clients waited to receive one-on-one post-
test counselling. HIV-negative clients received risk reduction
counselling. HIV-infected clients received counselling that was
informed by their POC CD4 result. This result was documented
on an individual-held “Road to HIV Health” card (Figure S1)
stratified by colour according to the urgency of referral to care.
Clients were advised to link to care within specific intervals:
clients with CD4 counts ≤200 cells/µl (ART-eligible), 201-350
cells/µl and ≥351 cells/µl were advised to link to care within
one, three and six months, respectively. These time intervals
were informed by the ART-eligibility criteria in the South African
National guidelines at the time [37]. Clients diagnosed with TB
symptoms, diabetes and/or hypertension were advised to link
to care within one month of diagnosis. Contact details for all
participants were documented on the mobile unit’s client
locator form. On this form client’s provided details on their
preferred method of contact (i.e. telephonically and/or home
visits) and additional details (i.e. contact number, physical
address, preferred name to use during follow-up). Clients could
opt out of receiving home-visits. Only HIV-infected clients were
followed-up telephonically by the counsellor one week post-
diagnosis to remind the client to link to care and offer additional
support as needed.
Study design
An observational cohort study was conducted between
January and November 2011. A mixed study design was used,
the first component involved a retrospective review of routine
clinical records to identify the yield of new diagnoses by
generating a list of clients newly-diagnosed with HIV (HIV-
infected cohort-primary screening service) and TB symptoms,
diabetes and/or hypertension (TB and other chronic diseases
cohort-additional screening services) at the mobile unit
between March 2010 and September 2011. All eligible clients
were sampled and then followed-up in the second component
of this study to assess linkage to care after the full
recommended time to link to care had passed (i.e. HIV-infected
CD4 ≤200 cells/µl: 1 month post-diagnosis, HIV+ CD4: 201-350
cells/µl: 3 months post-diagnosis, HIV+ CD4: ≥351 cells/µl: 6
months post-diagnosis, and TB suspects, diabetics and
hypertensives: 1 month post-diagnosis) (Table S1).
Clients eligible for follow-up had to be newly-diagnosed with
any one of the above conditions, ≥18 years of age and had to
provide contact details as well as consent for participation.
Clients were double-counted (i.e. a client could be in the HIV-
infected and TB and other chronic disease cohort).
Study procedures
Follow-up for assessment of linkage to
care.  Fieldworkers conducted follow-ups telephonically and/or
via home visits. At least seven telephonic attempts were made
for each client before a home visit. Clients who received a
maximum of 10 follow-up attempts and were not traced by the
end of the follow-up period were deemed “untraceable”.
Client’s diagnosed with more than one condition were followed-
up for each condition, after the pre-defined periods for linkage
for all conditions had elapsed.
Baseline data (i.e. age, sex, previous medical history) for all
mobile unit clients were available from routine client records.
Additional self-reported data including socioeconomic (i.e.
nationality, marital status, employment status, income, type of
dwelling, level of education), health seeking behaviour (i.e.
disclosure of HIV-infected status), clinical information (i.e.
repeat sputum taken, chest X-ray performed, repeat glucose
and/or blood-pressure reading taken, initiated ART or anti-TB/
diabetes/hypertension medication) and barriers to care were
obtained from the questionnaire and were only available for
individuals who were traced and participated in the study.
Study data were double-entered onto EpiData Entry (Version
3.1).
Primary outcomes
We defined the following primary outcomes with linkage to
care ascertained solely from client self-report:
Yield of new diagnoses: All clients newly-diagnosed with
HIV, one or more TB symptoms, diabetes and/or hypertension
between March 2010 and September 2011.
Linked to HIV care: A newly-diagnosed HIV-infected subject
who visited the clinic and was seen by a doctor, nurse or
counsellor at the healthcare facility for their referred condition
as indicated on their referral letter from the mobile unit, at least
once after diagnosis, within the following specific time-frames:
(CD4 ≤200 cells/µl: ≤1 month post-diagnosis, 201-350 cells/µl:
≤3 months post-diagnosis, ≥351 cells/µl: ≤6 months post-
diagnosis).
Linked to TB, diabetes and/or hypertension care: A TB
suspect or subject newly- diagnosed with diabetes and/or
hypertension who visited the clinic and was seen by a doctor,
nurse or counsellor at the healthcare facility for their referred
condition as indicated on their referral letter from the mobile
unit, at least once within one month post-diagnosis.
Individuals who were deceased, untraceable and those who
attempted but failed to link to care, never linked to care or
linked to care but not within the pre-defined period were
categorised as not having linked to care. If a client was
followed-up for multiple conditions, linkage to care was
assessed individually for each condition.
Sensitivity analysis
Additional analysis was conducted by investigating whether a
client ever accessed care (i.e. any time prior to follow-up) at
any healthcare facility at least once, regardless of the time-
frame for linkage.
Statistical analysis
Analyses were conducted using STATA (Version 11.0, Stata
Corporation. LP, College Station, TX, USA). Newly-diagnosed
HIV-infected individuals with POC CD4 counts ≥351 cells/µl
were underrepresented in the sample as only those diagnosed
in 2010 were enrolled into the study and thus 157 (52%) of
those diagnosed (300) were sampled. Alternatively, HIV-
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infected individuals with POC CD4 counts < 350 cells/µl were
oversampled as those diagnosed in 2010 and 2011 were
enrolled. Thus to minimise this sampling bias, sampling
weights for each CD4 count stratum were calculated and the
total proportions and means for each variable were adjusted for
these sample weights using the survey design command. Risk
ratios were assessed using Poisson regression to determine
clinical and socio-demographic factors predicting linkage to
care. Models for each condition (i.e. HIV-infected, TB
symptoms, diabetes and hypertension) were built separately.
Factors found to be associated with linkage in the univariate
analysis, at a 0.1 significance level, were advanced to a
multivariate analysis.
Ethics
Informed consent was obtained from all participants. Those
enrolled on the day of diagnosis in 2011 provided written
consent, those diagnosed before the start of the study (2010)
were followed-up telephonically and with a home visit (only if a
client could not be reached telephonically and the client gave
permission to be visited at home) for enrolment, and thus
provided verbal and written consent, respectively. Majority of
the follow-ups were conducted telephonically as this was more
feasible than a home visit and most clients preferred to be
contacted telephonically. The study including the consent
procedure was approved by the University of Cape Town
Research Ethics Committee (SA), and the Partners Healthcare
Human Research Committee (Protocol 2010P002636, Boston,
Massachusetts, USA).
Results
A total of 9,806 individuals were screened at the mobile unit
between March 2010 and September 2011 (Figure 1A). The
majority were female (58.5%) and the median age was 30
years (interquartile range [IQR]: 23-41). The disease-specific
prevalence was: newly-diagnosed HIV-infected (5.5%), TB
suspects (10.1%), newly-diagnosed diabetics (0.8%) and
newly-diagnosed hypertensives (58.1%).
Of the clients newly-diagnosed, a sub-sample of 777 clients
were eligible for participation in the linkage to care assessment:
294 in the HIV-infected cohort, and 504 in the TB and other
chronic diseases cohort (Figure 1B). There was no significant
difference in sex between those who were eligible for the
linkage to care assessment and those who were not. Of the
294 clients in the HIV-infected cohort, 18 were ineligible and
excluded after follow-up (refused n=4, followed-up before
prescribed time n=14). A total of 276 individuals remained in
the HIV-infected cohort analysis. Of the 504 clients in the TB
and other chronic diseases cohort, 16 clients deemed ineligible
were excluded after follow-up (refused n=2, followed-up before
prescribed time n=14). A total of 488 individuals remained in
this cohort, of whom 31 had more than one condition, bringing
the total number for analysis to 519 (TB suspects n=256,
diabetes n=31 and/or hypertension n=232). There was no
significant difference in sex in each group (i.e. TB suspects,
diabetics, hypertensives) compared to those who were not
sampled, except for the HIV-positive group (p=0.028).
Characteristics of clients in the HIV-infected cohort
(N=276)
The majority were female (63.9%), mean age was 34.1 years
and mean CD4 count was 481 cells/µl (Table 1A). Most clients
(87.4%) were referred for other conditions not evaluated here.
At the time of follow-up, the majority were in a relationship
(73.8%) and 53.8% were unemployed (Table S2-A). Nearly
two-thirds (66.3%) lived in informal dwellings and 87.8%
reported having disclosed their HIV-positive status.
Linkage to HIV care
Overall, 51.3% linked to care within the prescribed time-
frame for each CD4 stratum: (≤200 cells/µl: 37.5% ≤1 month,
201-350 cells/µl: 53.0% ≤3 months, ≥351 cells/µl: 53.1% ≤6
months) (Table 2A). In the sensitivity analysis, 60.0% of
participants accessed care at some point. Of the 18 ART-
eligible patients that linked to care within a month, 15 (83.3%)
started ART.
None of the variables examined with CD4 count (i.e. sex,
age, clinical stage, referred for other conditions, nationality,
employment status, marital status, monthly income, type of
dwelling, highest level of schooling achieved) revealed an
association with linkage to care except disclosure of HIV-
positive status to family members or partners (p= 0.04).
Controlling for CD4 count, newly-diagnosed HIV-infected
individuals who had disclosed their HIV-positive status to their
family member or partner were 2.6 times more likely to link to
HIV care than those who had not (95% CI: 1.04-6.3).
Characteristics of clients in the TB and other chronic
diseases cohort
TB suspects (N=256).  The median age was 38 years and
the majority were female (60.2%) (Table 1B). Over two-thirds
were unemployed (68.3%) and 38.7% resided in informal
dwellings (Table S2-B). Among those who linked to care
(56.7%), the majority had a sputum sample taken (82.8%)
(Table 2B); about one quarter had a chest X-ray done (24.8%).
A total of 9.7% TB suspects who linked to care initiated TB
treatment at a healthcare facility.
Diabetes (N=31).  The median age was 48 years, the
majority were female (58.1%) (Table 1B) and nearly two-thirds
were unemployed (65.4%) (Table S2-B). Of those who linked to
care (74.1%), the majority had a repeat glucose test performed
(91.3%) and 60.9% commenced anti-diabetic treatment at a
healthcare facility (Table 2B).
Hypertension (N=232).  The median age was 41 years and
more than half were female (55.2%) (Table 1B). Most clients
were unemployed (54.9%) (Table S2-B). Among hypertensives
who linked to care (50.0%), more than 90% had a repeat blood
pressure reading and almost two-thirds (65.5%) started anti-
hypertensive medication at a healthcare facility (Table 2B).
Predictors for linkage to care for TB and other chronic
diseases
No covariates for linkage to care were statistically significant
in any of the three models.
Linkage to Care from a Mobile Testing Unit
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Barriers to care
Participants reported the following as the main reasons for
failing to link to HIV care: lost referral letter (18.8%), insufficient
time during the day to attend a clinic (15.6%) or relocated
(12.5%) (Table 3A). The majority of TB suspects, diabetics and
hypertensives who failed to link to care reported having
insufficient time to attend a weekday clinic due to competing
priorities during the day (TB suspects 70.5%, diabetics 50.0%,
hypertensives 68.9%) (Table 3B).
Discussion
Addition of both communicable and non-communicable
disease screening to existing HCT services may be effective in
resource-constrained settings. This study evaluated a multiple
disease screening service delivered through a mobile unit in
Cape Town. Results show not only that the yield of newly-
diagnosed HIV infection (5.5%) is high from this mobile unit,
but also that this platform can be used to effectively identify TB
Figure 1.  Schematic of the study inclusion and exclusion pathway.  Of the 9,806 clients screened at the mobile unit between
March 2010 and September 2011, 276 were eligible for follow-up in the HIV-infected cohort and 488 were eligible for follow-up in the
TB and other chronic diseases cohort. 1A: ^=of the 541 newly-diagnosed HIV-infected clients, 512 (95%) had a POC CD4 count
done, of whom 502 (98%) received their CD4 count result. *= The yield of new diagnoses indicates the proportion of clients
screened and who were newly-diagnosed with HIV, 1 or more TB symptoms, diabetes and hypertension, in that specific hierarchical
order. Individuals have not been double-counted. 1B: ^^= There was no significant difference in sex between those that were eligible
and those ineligible to participate (p=0.13). $= 21 TB suspects were also newly-diagnosed with HIV. Thus the total number of clients
that met the study’s eligibility criteria is less than the cumulative number of clients in the HIV-infected cohort (n=294) and TB and
other chronic diseases cohort (n=504), as it excludes these 21 TB suspects from the TB and other chronic diseases cohort who are
accounted for in the HIV-infected cohort. A large proportion of clients did not meet the study’s eligibility criteria due to several
reasons (i.e. were HIV-negative or known HIV-positive patients, were known TB suspects/diabetics/hypertensives, were diagnosed
outside the pre-specified study enrolment period, left without obtaining a referral letter or consent, had no locator details, were < 18
years);. $$= each individual is represented once in one of the three groups (i.e. TB symptoms, diabetes, hypertension);
#=individuals that did not receive the full allotted time to link to care and self-reported they never linked to care or attempted but
failed to link to care were excluded from the analysis.
doi: 10.1371/journal.pone.0080017.g001
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suspects (10.1%) and diagnose diabetics (0.8%) and
hypertensives (58.1%). While linkage to care was just over
50% for subjects in the HIV-infected cohort and TB suspects
and other chronic diseases cohort, these estimates are
comparable to that reported for facility-based screening
[21,38-43].
Among newly-diagnosed HIV-infected clients, 51.3% linked
to care within pre-defined periods. After the implementation of
a POC CD4 count machine on this mobile unit, an increased
proportion of clients were able to receive their CD4 results
(98%) compared to when laboratory-based CD4 count testing
was performed on the same unit as shown in an earlier study
(73%) (p= 0.01) [22]. The proportion of those who ever linked
to HIV care in this study (60.0%) is also higher than those ever
linked to care after having received a laboratory CD4 count in a
previous study (52.5%) (p= 0.22) (Table S3-A) [22]. A similar
trend was reported on a mobile unit in Johannesburg, whereby
61% of HIV-infected clients receiving a POC CD4 result linked
to care, compared to 42% who underwent laboratory CD4
count testing [44]. However, a community campaign from rural
Uganda that offered clients POC CD4 testing and transport fare
to a clinic reported poor linkage to HIV care (34% within three
months post-diagnosis) [14]. The current study indicates the
benefits of having a POC CD4 machine on a mobile unit. In
addition to providing a baseline CD4 count result to nearly all
clients newly-diagnosed HIV-positive on the day of diagnosis,
having the client’s CD4 count result during post-test counseling
assisted mobile unit nurses and counsellors in providing
counseling specific to the client’s stage of infection, furthermore
it allowed staff to graphically illustrate to clients on their Road
to HIV Health Card (Appendix 1) where they were in their stage
of infection and what HIV services should be provided to them
once they link to care at their healthcare facility.
Two-thirds of ART-eligible clients ever linked to ART care
(66.7%) in the current study, yet linkage to care within one
month of diagnosis among this group was just over one-third
(37.5%), which suggests that prompt linkage to care among
ART-eligible patients remains a challenge. A recent systematic
review showed that a median of 68% (range: 14%-84%) of
ART-eligible patients initiate ART in SSA [45]. Our findings are
consistent with the upper end of this range, as 83.3% of the 18
who linked to care started ART within one month post-
diagnosis. Time to ART initiation was shorter in this study than
that found in an earlier study, in which majority (69.2%) had
commenced ART only within two months post-diagnosis [22].
These results indicate the combined need for intensive
interventions to ensure ART-eligible patients link to care and
initiate ART promptly. Such interventions could include
Table 1. Description of baseline clinical and socio-demographic characteristics of clients in each cohort.
A. HIV-infected cohort (N=276)
BASELINE^ Total CD4 ≤200 CD4 201-350 CD4 ≥351
 (N=276) cells/µl cells/µl cells/µl
 % (95% CIa) (N=48) % (n) (N=83) % (n) (N=145) % (n)
Age (mean years) 34.1 (32.9-35.3) 35.0 35.3 33.6
Sex (Female)* 63.9 (58.0-69.8) 60.4 (29) 48.2 (40) 68.9 (100)
WHOb clinical stage (I vsc. II, III, IV) 57.2 (51.1-63.2) 45.8 (22) 37.8 (31) 64.6 (93)
POCd CD4 count (mean cells/µl) 481 (458-505) 135 280 597
Additional morbidity     
TBe suspect (vs. Known TB suspect/Known TB/Previous TB/No TB symptoms) 4.3 (2.4-6.1) 14.6 (7) 13.3 (11) 0
Newly diagnosed-diabetic (vs. Known diabetic/Not diabetic) 0 0 0 0
Newly diagnosed-hypertensive (vs. Known hypertensive/Not hypertensive) 1.9 (0.4-3.4) 4.2 (2) 4.8 (4) 0.7 (1)
Referred for other conditions (Yes)$ 87.4 (83.2-91.7) 95.8 (46) 89.2 (74) 85.5 (124)
B. TB and other chronic diseases cohort (N=519)
BASELINE^ TB Suspects Diabetics Hypertensives
 (N=256) % (n) (N=31) % (n) (N=232) % (n)
Age (median years, [IQR]f) 38 [31-50] 48 [38-54] 41 [34-51]
Sex (Female)* 60.2 (154) 58.1 (18) 55.2 (128)
Additional morbidity:    
Newly diagnosed-HIV-positive (vs. Known HIV-positive/HIV-negative) 25.4 (62) 3.2 (1) 5.7 (12)
TB suspect (vs. Known TB suspect/Known TB patient/Previous TB/No TB symptoms) N/A 6.3 (2) 9.1 (21)
Newly diagnosed-diabetic (vs. Known diabetic/Not diabetic) 0.8 (2) N/A 3.5 (8)
Newly diagnosed-hypertensive (vs. Known hypertensive/Not hypertensive) 8.2 (21) 25.9 (8) N/A
Referred for other conditions (Yes)$ 68.8 (176) 67.7 (21) 52.2 (121)
^ baseline data from routine clinical records were available for all clients; $= conditions other than HIV, TB symptoms, diabetes, hypertension; * there was a significant
difference in sex between those in the HIV cohort and those not sampled (p=0.028); ** there was no significant difference in sex among TB suspects (p value=0.49),
diabetics (p=0.090) and hypertensives (p=0.752) versus those not sampled.
a= confidence interval, b=World Health Organisation, c= versus, d= point-of-care, e=tuberculosis, f=interquartile range
doi: 10.1371/journal.pone.0080017.t001
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transport vouchers, community escorts and supportive
counselling as demonstrated in Tanzania [46]. Only half of the
pre-ART clients linked to care within three and six month’s
post-diagnosis in the CD4 201-350 cells/µl and ≥351 cells/µl
strata, respectively, consistent with a study from Uganda which
showed that a high baseline CD4 count (≥250 cells/µl) was
among the risk factors for not enrolling into HIV care [47].
Possible interventions which could improve linkage to care
among pre-ART clients include provision of medical (i.e.
cotrimoxazole [48], contraception) and non-medical incentives
(food hampers) [49] or psycho-social support (peer support)
[50].
We found that disclosure of one’s newly-diagnosed HIV-
positive status to a family member or partner was significantly
associated with linkage to care. Disclosure was also found to
be a predictor for linkage to care [51] and ART uptake [52] in
studies conducted in Kenya. It is plausible that those who
encounter less stigma are more likely to disclose their status
than those who do not and thus are also more comfortable with
accessing care. Alternatively, participants who accessed care
and received intensive pre-ART or ART counselling may have
been encouraged to disclose their HIV-positive status.
This study showed that the yield of TB suspects was high
and comparable to the yield of newly-diagnosed HIV-infected
clients and is expected to be markedly higher if the revised
national TB screening criteria is employed which includes
cough of any duration [53]. Just over half of the TB suspects
accessed care within one month after screening, which is
consistent with a study conducted in rural Uganda which
reported 52% linkage to TB care [14]. However, this is a public
Table 2. Study outcomes in each cohort: percentage linked to care and percentage ever linked to care.
A. HIV-infected cohort (N=276)
 Total CD4 ≤200 CD4 201-350 CD4 ≥351
 (N=276) cells/µl cells/µl cells/µl
 % (95% CIa) (N=48) % (n) (N=83) % (n) (N=145) % (n)
Linked to HIV care within pre-defined period     
Yes 51.3 (45.1-57.6) 37.5 (18) 53.0 (44) 53.1 (77)
If ARTb-eligible, started ART  83.3 (15) N/A N/A
No# 48.7 (42.4-54.9) 62.5 (30) 47.0 (39) 47.0 (68)
Ever linked to HIV care before follow-up     
Yes 60.0 (54.2-66.5) 66.7 (32) 62.7 (52) 58.6 (85)
No$ 40.0 (42.4-54.9) 33.3 (16) 37.3 (31) 41.4 (60)
B. TB and other chronic diseases cohort (N=519)
 TBc Suspects Diabetics Hypertensives
 (N=256) % (n) (N=31) % (n) (N=232) % (n)
Linked to care within pre-defined period    
Yes 56.7 (145) 74.1 (23) 50.0 (116)
If TB suspect    
Sputum sample taken at the healthcare facility (Yes) 82.8 (120) N/A N/A
Chest X-ray performed (Yes) 24.8 (36) N/A N/A
Started TB treatment (Yes) 9.7 (14) N/A N/A
If diabetic    
Repeat glucose test performed at the healthcare facility (Yes) N/A 91.3 (21) N/A
On anti-diabetic medication (Yes) N/A 60.9 (14) N/A
If hypertensive    
Repeat blood pressure test performed at the healthcare facility(Yes) N/A N/A 94.8 (110)
Started anti-hypertensive medication (Yes) N/A N/A 65.5 (76)
No# 43.3 (111) 25.9 (8) 50.0 (116)
Ever linked to care before follow-up    
Yes 56.7 (145) 74.1 (23) 59.0 (137)
No$ 43.3 (111) 25.9 (8) 41.0 (95)
#. individuals that were deceased, untraceable as well as those that never linked to care, attempted but failed to link to care or linked to care but not within the time-frame;
$= individuals that were deceased, untraceable, and those that never linked to care or attempted but failed to link to care.
a= confidence interval, b=antiretroviral therapy, c=tuberculosis
doi: 10.1371/journal.pone.0080017.t002
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health concern as those who had TB and failed to link within
the recommended time could have potentially transmitted TB in
their communities. Noteworthy is that of the TB suspects who
linked to care in this study a high proportion had sputum taken
at the healthcare facility (82.8%) and10% initiated TB
treatment. This is in line with current WHO guidelines, which
assume that national TB programmes in resource-limited
settings should screen an average of 10 suspects to identify
one smear-positive case [54].
The proportion of clients newly-diagnosed with hypertension
in our study (58.1%) was substantially higher than that reported
in a Kenyan study (30%)[12]. In South Africa, most studies
have assessed hypertension at blood pressure readings
≥140/90 mmHg and have found the prevalence to be in the
range of 30-55% [55-57]. The hypertension epidemic in South
Africa has been largely attributed to the increase in
urbanisation and subsequent adoption of poor eating habits
(i.e. high salt intake) and lack of physical activity[58-63]. The
high hypertension prevalence documented in our study is likely
Table 3. Barriers to care.
A. HIV-infected cohort
QUESTIONNAIRE^^ Total CD4 ≤200
CD4
201-350 CD4 ≥351
 (N=211) cells/µl cells/µl cells/µl
 % (95% CIa) (N=39) % (n)
(N=63) %
(n)
(N=109) %
(n)
Failed to link to care
(N=42)**
15.7
(11.1-20.3) 7 11 24
Reasons for not
accessing care
1 missing
value   
1 missing
value
1. Lost referral letter 18.8(5.3-32.2) 14.3 (1) 9.1 (1) %1.1 (5)
2. No time to attend a
healthcare facility
15.6
(4.7-26.5) 28.6 (2) 36.4 (4) %1.1 (2)
3. Relocated to a new
area
12.5
(0.8-24.2) 0 0 %1.1 (4)
B. TB and other chronic diseases cohort
QUESTIONNAIRE^^ TB Suspects Diabetics Hypertensives
 (N=208) % (n) (N=26) % (n) (N=204) % (n)
Failed to link to care ** (63) (3) (67)
Reasons for not
accessing care 2 missing values
1 missing
value
6 missing
values
1. No time to attend a
healthcare facility 70.5 (43) 50.0 (1) 68.9 (42)
2. Healthcare facility was
too full and was given a
date to return
6.6 (4)  6.6 (4)
3. Lost the referral letter 3.3 (2)  4.9 (3)
^^. data from the questionnaires were only available for clients that were traced
and participated in the study;
**. Indicates reported barriers to care for participants who never linked to care or
attempted but failed to link to care
a= confidence interval
doi: 10.1371/journal.pone.0080017.t003
reflective of this trend as well. Linkage to care among those
newly-diagnosed with hypertension in our study (50.0%) was
similar to that reported in a Ugandan study (43%) [14], and of
those who linked to care; the majority had repeated blood
pressure measurements and commenced anti-hypertension
medication (65.5%). Linkage to care among newly-diagnosed
diabetics was slightly higher in this study (74.1%) compared to
that found in a study from Uganda (61%) [14], with 60.9% who
had started on anti-diabetic medication.
Not having time during the day to visit a clinic was a
commonly stated barrier to care for all groups, and has been
reported in other studies from this region [64]. Clinics that
operate after-hours and on weekends could help to circumvent
this problem. The loss of one’s referral letter and relocation
were the main barriers to care in the HIV-infected cohort.
These findings point to the need for counsellors to emphasise
to clients the value of a referral letter for accessing care in any
location and that one can access care even if the letter is
misplaced. Furthermore, it highlights the need for mobile
testing programmes to link their newly-diagnosed HIV-infected
clients with community healthcare workers who can support
clients in their entry to care [46].
This study is subject to several limitations. A larger
proportion of clients screened did not meet the strict eligibility
criteria for the assessment of linkage to care due to several
reasons (i.e. were HIV-negative or were a known HIV-infected
individual/TB suspect/diabetic/hypertensive client, were newly-
diagnosed outside the pre-specified study enrolment period,
left without obtaining a referral letter or consent, had no locator
details), and thus linkage was only assessed in 10% (777) of
those screened. Sampling bias might have been introduced as
it was not feasible to sample all HIV-infected subjects in the
CD4 ≥201 cells/µl stratum newly-diagnosed in 2011, since
follow-up could only commence once the recommended time-
frame for linkage had lapsed (i.e. after three to six months post-
diagnosis). However, total proportions were calculated based
on sample weighting. The small sample size in the CD4 ≤200
cells/µl stratum and the diabetes group resulted in limited
power to detect associations. Clients diagnosed in 2010 were
followed-up almost 10 months post-diagnosis, which made
tracing challenging. More than 10% in each disease group
were untraceable despite multiple attempts (HIV cohort 22%,
TB suspects=18%, diabetes=16%, hypertension=12%).
Misclassification of an individual as hypertensive cannot be
excluded and might have resulted in a biased prevalence
estimate, furthermore misclassification of linkage to care,
additional follow-up tests and initiation of treatment at the
healthcare facility may have also occurred as these data were
ascertained through participant self-reports. Nevertheless, a
previous study by our group showed that the sensitivity of self-
reported linkage to care is good [22]. Recall and social
desirability bias may have also influenced findings pertaining to
disclosure, clinic visit date and barriers to care. Data on the
telephonic follow-ups conducted by the mobile unit counsellors
one week post-diagnosis was of sub-optimal quality and thus
the association of successful contact on linkage to care could
not be assessed. Follow-up of clients in our previous study
several months after diagnosis did prove to be challenging as
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often locator details were missing and field staff were limited.
However, following the previous study mobile staff were trained
to obtain detailed locator details (i.e. alternate address, contact
number, test mobile numbers on site) and thus the exact
methods of follow-up were used on this study and more
fieldworkers were employed.
This study also has several strengths. Trained and
experienced counsellors conducted follow-ups (telephone calls
and/or home visits) to ascertain outcomes in the clients
preferred language to minimise respondent bias. Clients
received no incentive for participation. Care at this mobile unit
and care received at most of the healthcare facilities
participants attended was free of charge, thus these results
could be generalisable to similar settings. Mobile units are now
widely implemented across SSA [15-31,44], and these results
can inform policy makers considering adding screening for
other infectious and non-infectious diseases. The primary
outcome included a pre-specified time cut-off for linkage which
may allow for easier comparisons to be made with future
studies [45].
In conclusion, this study suggests that it is worthwhile to add
screening for TB symptoms and hypertension to existing
mobile HIV testing services, as the yield for all three conditions
is substantial. This study confirmed the feasibility of POC CD4
testing on mobile HIV services and demonstrated how this
information could enhance post-test counseling, specifically for
ART-ineligible patients, although stronger efforts are needed to
encourage linkage within one month post-diagnosis among
ART-eligible patients. Linkage to care for HIV, TB and other
chronic conditions, although comparable to that observed at
healthcare facilities, must be improved to fully realise the public
health impact of earlier screening and diagnosis. More flexible
clinic operating hours, emphasis on the importance of a referral
letter, and linking newly-diagnosed HIV-infected clients to
patient facilitators may assist clients in overcoming barriers to
care. Disclosure of one’s HIV-positive status to a family
member or partner was associated with better linkage to HIV
care. Integrated HIV, TB symptoms and NCD screening in
mobile units holds promise for expanding the scope of HIV
services and the reach of primary healthcare.
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